Suppr超能文献

血浆凝血酶活性的特异性测定。

Specific determination of plasmatic thrombin activity.

作者信息

Stief T W

机构信息

Department of Clinical Chemistry, University Hospital, Giessen & Marburg, Germany.

出版信息

Clin Appl Thromb Hemost. 2006 Jul;12(3):324-9. doi: 10.1177/1076029606291381.

Abstract

Thrombin is the key enzyme of coagulation. Its activity can be determined via fibrinogen Ø fibrin conversion or via cleavage of a chromogenic substrate. The latter method is easier than the first one, but in plasma it is hampered due to unspecific cleavage of the chromogenic substrate by thrombin-like enzymes of hemostasis, especially those of the contact phase. The concentration of the thrombin substrate (HD-CHG-Ala-Arg-pNA) was optimized, using final substrate concentrations of 0 to 5 mM, a final arginine concentration of 1.13 M, and samples of 10 mIU/mL purified thrombin in 7% human albumin or pooled normal citrated plasma without and with EDTA. Twenty microliters pooled normal citrated plasma (frozen/thawed) or factor II-deficient plasma (lyophilized) were incubated with 10 microL 0% to 0.5% Thromborel S (100% = 162 ng/mL tissue factor [TF]) in 6% BSA or with 10 microL 0% (physiol. NaCl) to 50% Pathromtin SL and with 20 microL 25 mM CaCl(2). After 0 to 22 minutes (37 degrees C), 20 microL 1.7 M arginine, pH 8.7 were added. Fifteen microliters 0.9 mM HD-CHGAla-Arg-pNA in 2.3 M arginine, pH 8.6, were added and the increase in absorbance (deltaA) at 405 nm was determined. Thrombin activity was standardized against the (3)A measured for 1 IU/mL thrombin in 7% human albumin (8.8 mA/min RT). The optimal final chromogenic substrate concentration to detect thrombin in this assay system is less than 0.6 mM. Higher substrate concentrations in a plasma milieu result in unspecific cleavage of the substrate. Using final concentrations of chromogenic substrate less than 0.4 mM (the approximate Km- value for thrombin) and final concentrations of arginine greater than 800 mM, in factor II-depleted plasma, when activated either by TF or by the contact phase, there is no significant thrombin generation. The circulating thrombin activity measured in EDTA plasma of 39 healthy donors is 100 +/- 20% of norm (mean value +/- 1 SD; 100% = 5.5 mIU/mL thrombin). This chromogenic assay detects thrombin activity independent of clotting seconds or fibrin mediated turbidity increases. This technique allows to standardize the thrombin activity generated in any biologic system in international thrombin units.

摘要

凝血酶是凝血的关键酶。其活性可通过纤维蛋白原向纤维蛋白的转化或通过显色底物的裂解来测定。后一种方法比前一种更容易,但在血浆中,由于止血过程中类似凝血酶的酶,特别是接触相的酶对显色底物的非特异性裂解,该方法受到阻碍。优化了凝血酶底物(HD-CHG-Ala-Arg-pNA)的浓度,使用的最终底物浓度为0至5 mM,最终精氨酸浓度为1.13 M,以及在7%人白蛋白或无EDTA和有EDTA的混合正常枸橼酸盐血浆中10 mIU/mL纯化凝血酶的样本。将20微升混合正常枸橼酸盐血浆(冻融)或因子II缺乏血浆(冻干)与10微升6%牛血清白蛋白中0%至0.5%的Thromborel S(100% = 162 ng/mL组织因子[TF])或与10微升0%(生理氯化钠)至50%的Pathromtin SL以及20微升25 mM氯化钙一起孵育。在0至22分钟(37℃)后,加入20微升1.7 M精氨酸,pH 8.7。加入15微升2.3 M精氨酸、pH 8.6中的0.9 mM HD-CHG-Ala-Arg-pNA,并测定405 nm处吸光度的增加(ΔA)。针对在7%人白蛋白中1 IU/mL凝血酶测得的(3)A(8.8 mA/min RT)对凝血酶活性进行标准化。在该检测系统中检测凝血酶的最佳最终显色底物浓度小于0.6 mM。血浆环境中较高的底物浓度会导致底物的非特异性裂解。在因子II缺乏的血浆中,当通过TF或接触相激活时,使用小于0.4 mM的显色底物最终浓度(凝血酶的近似Km值)和大于800 mM的精氨酸最终浓度,不会有显著的凝血酶生成。在39名健康供体的EDTA血浆中测得的循环凝血酶活性为正常水平的100±20%(平均值±1标准差;100% = 5.5 mIU/mL凝血酶)。这种显色测定法检测凝血酶活性,与凝血秒数或纤维蛋白介导的浊度增加无关。该技术允许以国际凝血酶单位对任何生物系统中产生的凝血酶活性进行标准化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验